Spotlight: Lesbian, gay and bisexual men and women in England report poorer health and worse experiences of healthcare in the NHS

Our analysis of 27,000 responses to the national GP Patient Survey finds gay, lesbian and bisexual people are more likely to report communication problems and have less trust in their GP…

Why has the Welsh government approved Sativa for multiple sclerosis and not NICE in England?

Sativa is a nasal spray based on a cannabis extract which is used for painful muscle cramps in multiple sclerosis. There doesn’t seem much doubt that it works, and in its most recent draft guidance on MS, NICE has based it’s decision on cost effectiveness grounds – the benefit came out at £49,300 per QALY …read more

Posted in Blog | Tagged , , | Leave a comment

Medication errors in primary care in the developing world

worldmap pills

Global spending on pharmaceuticals is roughly a $1 trillion, dominated by the US, Japan and major EU economies. Yet emerging markets and the developing world still account for around a third of expenditure. That’s a lot of medicines and it’s growing. With this substantial use of medications comes a significant risk of harm, compounded by …read more

Posted in Blog | Tagged , , | Leave a comment

Asking the right questions

One of the great things about Twitter is that you get to read other peoples’ takes on things. Matthew Hankins, for example, posts people’s interpretations of p-values (under the hashtag #stillnotsignificant), which are more entertaining than you might think. A few weeks ago he posted the conclusion from a paper which read: “we were quite …read more

Posted in Blog | Tagged , , , | Leave a comment

mH2 – the future of mental healthcare

Mental healthcare is often described as the Cinderella of medicine – overlooked, disparaged, and generally neglected. In the UK, mental healthcare is the single biggest item on the NHS budget (£12.16bn in 2010/11), but in practice this means that only about 11% of the overall spend is allocated to deal with 23% of the disease …read more

Posted in Blog | Tagged , , | Leave a comment

Care plans and care planning: a rare event?

Have you seen a care plan recently? Despite a massive effort, we didn’t see many in our national evaluation of care plans and care planning. Our new paper reports the findings of this work, summarised here.

Posted in Blog | Tagged , , , , | Leave a comment

NICE and Roche at loggerheads (again)

kadcyla

  NICE has today (8th August 2014) announced that it cannot recommend Roche’s latest breast cancer drug, Kadcyla (a combination of trastuzumab and emtansine) for routine use on the NHS because it is too expensive and hence not cost-effective.  The draft ‘no’ was actually published in May, but there has been a press release issued today …read more

Posted in Blog, News | Tagged , | Comments closed

Does pay for performance work or doesn’t it?

Martin Roland discusses the effects of pay for performance, following on from our study published in the New England Journal of Medicine this week.

Posted in Blog | Tagged , , , | Comments closed

Medicalising life

Medicines have been getting into the mainstream news quite a lot in recent times. A couple of days ago saw the publication in Annals of Oncology of a review of the evidence for a protective effect of aspirin in reducing cancer in the general population. The role of aspirin in cardiovascular disease prevention is well …read more

Posted in Blog | Tagged , , , , | Comments closed

Let not thy will roar, when thy power can but whisper

Does power matter when using routine data and is there a point in performing a sample size/power calculation? Gary argues yes and yes!

Posted in Blog, Stats | Tagged | Comments closed
  • The Cambridge Centre for Health Services Research (CCHSR) is a collaboration between the University of Cambridge Health Services Research Group at the Institute of Public Health and the Health and Healthcare Group at RAND Europe. We aim to inform policy through evidence-based research on health services in the UK and internationally.